Physiological basis for xenotransplantation from genetically modified pigs to humans
- PMID: 38517040
- PMCID: PMC11390123
- DOI: 10.1152/physrev.00041.2023
Physiological basis for xenotransplantation from genetically modified pigs to humans
Abstract
The collective efforts of scientists over multiple decades have led to advancements in molecular and cellular biology-based technologies including genetic engineering and animal cloning that are now being harnessed to enhance the suitability of pig organs for xenotransplantation into humans. Using organs sourced from pigs with multiple gene deletions and human transgene insertions, investigators have overcome formidable immunological and physiological barriers in pig-to-nonhuman primate (NHP) xenotransplantation and achieved prolonged pig xenograft survival. These studies informed the design of Revivicor's (Revivicor Inc, Blacksburg, VA) genetically engineered pigs with 10 genetic modifications (10 GE) (including the inactivation of 4 endogenous porcine genes and insertion of 6 human transgenes), whose hearts and kidneys have now been studied in preclinical human xenotransplantation models with brain-dead recipients. Additionally, the first two clinical cases of pig-to-human heart xenotransplantation were recently performed with hearts from this 10 GE pig at the University of Maryland. Although this review focuses on xenotransplantation of hearts and kidneys, multiple organs, tissues, and cell types from genetically engineered pigs will provide much-needed therapeutic interventions in the future.
Keywords: genetically modified pigs; xenotransplantation.
Conflict of interest statement
L.P., D.A., W.E., and M.R. are employees of United Therapeutics. M.Y. is on the scientific advisory board of United Therapeutics. J.H.U. and U.M.B. have scientific research agreements with United Therapeutics. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.
Figures
Similar articles
-
Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps.Front Immunol. 2022 Dec 6;13:1031185. doi: 10.3389/fimmu.2022.1031185. eCollection 2022. Front Immunol. 2022. PMID: 36561750 Free PMC article. Review.
-
Xenotransplantation: Current Status in Preclinical Research.Front Immunol. 2020 Jan 23;10:3060. doi: 10.3389/fimmu.2019.03060. eCollection 2019. Front Immunol. 2020. PMID: 32038617 Free PMC article. Review.
-
The role of genetically engineered pigs in xenotransplantation research.J Pathol. 2016 Jan;238(2):288-99. doi: 10.1002/path.4635. Epub 2015 Oct 7. J Pathol. 2016. PMID: 26365762 Free PMC article. Review.
-
Xenotransplantation of solid organs in the pig-to-primate model.Transpl Immunol. 2009 Jun;21(2):87-92. doi: 10.1016/j.trim.2008.10.005. Epub 2008 Oct 26. Transpl Immunol. 2009. PMID: 18955143 Review.
-
The Case for Cardiac Xenotransplantation in Neonates: Is Now the Time to Reconsider Xenotransplantation for Hypoplastic Left Heart Syndrome?Pediatr Cardiol. 2019 Feb;40(2):437-444. doi: 10.1007/s00246-018-1998-1. Epub 2018 Oct 9. Pediatr Cardiol. 2019. PMID: 30302505 Review.
Cited by
-
Revolutionizing Donor Heart Procurement: Innovations and Future Directions for Enhanced Transplantation Outcomes.J Cardiovasc Dev Dis. 2024 Jul 27;11(8):235. doi: 10.3390/jcdd11080235. J Cardiovasc Dev Dis. 2024. PMID: 39195143 Free PMC article. Review.
-
Application of Methods Detecting Xenotransplantation-Relevant Viruses for Screening German Slaughterhouse Pigs.Viruses. 2024 Jul 11;16(7):1119. doi: 10.3390/v16071119. Viruses. 2024. PMID: 39066281 Free PMC article.
References
-
- Organ Donation Statistics (Online). 2023. https://www.organdonor.gov/learn/organ-donation-statistics. [2023 Oct 17].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources